| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 2 | +17.6K | 3.2% | $9.11 | +$160K |
| Sells | 8 | -537K | 96.8% | $10.92 | -$5.86M |
| Net | -6 | -519K | -93.7% | -$5.7M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Alexander J. Denner | Director, 10%+ Owner | $67.5M | Dec 16, 2024 | ||
| Thomas A. MCCOURT | Chief Executive Officer, Director | $5.3M | -$3.14M | -37.2% | Jan 17, 2025 |
| Jason Rickard | SVP, Chief Operating Officer | $4.21M | Mar 8, 2023 | ||
| Mark G. Currie | Director | $3.58M | Jun 18, 2024 | ||
| Edward P. Owens | Director | $3.15M | Jun 2, 2021 | ||
| Michael Shetzline | SVP, CMO, Head-Res&Drug | $1.88M | -$693K | -26.9% | Jan 17, 2025 |
| Minardo John | Chief Legal Officer | $1.33M | -$877K | -39.8% | Jan 17, 2025 |
| Sravan Kumar Emany | SVP, COO and CFO | $1.26M | +$55.3K | +4.58% | Nov 18, 2024 |
| Ronald Silver | Principal Accounting Officer | $1.19M | -$134K | -10.1% | Jan 27, 2025 |
| Andrew Dreyfus | Director | $1.18M | Jun 18, 2024 | ||
| Andrew Davis | SVP, Chief Business Officer | $1.16M | -$318K | -21.5% | Nov 18, 2024 |
| Julie McHugh | Director | $1.03M | -$143K | -12.2% | Jun 18, 2024 |
| Lawrence S. Olanoff | Director | $1.02M | Jun 2, 2021 | ||
| Jon R. Duane | Director | $914K | +$60.2K | +7.05% | Jun 18, 2024 |
| Gregory S. Martini | Chief Financial Officer | $799K | Jan 27, 2025 | ||
| Jay Shepard | Director | $796K | Jun 18, 2024 | ||
| Marla L. Kessler | Director | $760K | Jun 18, 2024 | ||
| Catherine Moukheibir | Director | $459K | -$518K | -53% | Jun 18, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|